• ABRAMSON, S.B., LESZCZYNSKA-PIZIAK, J., CLANCY, R.M., PHILIPS, M. & WEISSMANN, G. (1994). Inhibition of neutrophil function by aspirin-like drugs (NSAIDs): Requirement for assembly of heterotrimeric G proteins in bilayer phospholipid. Biochem. Pharmacol., 47, 563572.
  • BOYCE, S., CHAN, C.-C., GORDON, R., LI, C.S., RODGER, I.W., WEBB, J.K., RUPNIAK, N.M.J. & HILL, R.G. (1994). L-745,337: a selective inhibitor of cyclooxygenase-2 elicits antinociception but not gastric ulceration in rats. Neuropharmacology, 33, 16091611.
  • CHAN, C.-C., BOYCE, S., BRIDEAU, C., FORD-HUTCHINSON, A.W., GORDON, R., GUAY, D., HILL, R.G., LI, C.S., MANCINI, J., PENNETON, M., PRASIT, P., RASORI, R., REINDEAU, D., ROY, P., TAGARI, P., VICKERS, P., WONG, E. & RODGER, I.W. (1995). Pharmacology of a selective cyclooxygenase-2 inhibitor, L-745,337: A novel nonsteroidal anti-inflammatory agent with an ulcerogenic sparing effect in rat and nonhuman primate stomach. J. Pharmacol. Exp. Ther., 274, 15311537.
  • EDWARDS, J.C.W., SEDGWICK, A.D. & WILLOUGHY, D.A. (1981). The formation of a structure with features of synovial lining by subcutaneous injection of air: an in vivo tissue culture system. J. Pathol., 134, 147156.
  • FAMAEY, J.P. (1997). In vitro and in vivo pharmacological evidence of selective cyclooxygenase-2 inhibition by nimesulide: an overview. Inflamm. Res., 46, 437446.
  • GILROY, D.W., TOMLINSON, A. & WILLOUGHBY, D.A. (1998). Differential effects of inhibition of isoforms of cyclooxygenase (COX-1, COX-2) in chronic inflammation. Inflamm. Res., 47, 7985.
  • GRETZER, B., KNORTH, H., CHANTRAIN, M., BARBERA, L., WILLBURGER, R.E., WITTENBERG, R.H. & PESKAR, B.M. (1998). Effects of diclofenac and L-745,337, a selective cyclooxygenase-2 inhibitor, on prostaglandin E2 formation in tissue from human colonic mucosa and chronic bursitis. Gastroenterology, 114, A139.
  • KARGMAN, S., CHARLESON, S., CARTWRIGHT, M., FRANK, J., RIEANDEAU, D., MANCINI, J., EVANS, J. & O'NEILL, G. (1996). Characterization of prostaglandin G/H synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts. Gastroenterology, 111, 445454.
  • KUJUBU, D.A., FLETCHER, B.S., VARNUM, B.C., LIM, R.W. & HERSCHMAN, H.R. (1991). TIS10, a phorbol ester tumor promoter-inducible mRNA from swiss eTe cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J. Biol. Chem., 266, 1286612872.
  • LEBLANC, Y., GAUTHIER, J.Y., ETHIER, D., GUAY, J., MANCINI, J., RIENDEAU, D., TAGARI, P., VICKERS, P., WONG, E. & PRASIT, P. (1995). Synthesis and biological evaluation of 2,3-diarylthiophenes as selective COX-2 and COX-1 inhibitors. Bioorg. Med. Chem. Letters, 5, 21232128.
  • MASFERRER, J.L., ZWEIFEL, B.S., MANNING, P.T., HAUSER, S.D., LEAHY, K.M., SMITH, W.G., ISAKSON, P.C., SEIBERT, K. (1994). Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc. Natl. Acad. Sci. U.S.A., 91, 32283232.
  • MIZUNO, H., SAKAMOTO, C., MATSUDA, K., WADA, K., UCHIDA, T., NOGUCHI, H., AKAMATSU, T. & KASUGA, M. (1997). Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antogonist delays healing in mice. Gastroenterology, 112, 387397.
  • NAKATSUGI, S., TERADA, N., YOSHIMURA, T., HORIE, Y. & FURUKAWA, M. (1996). Effects of nimesulide, a preferential cyclooxygenase-2 inhibitor, on carrageenan-induced pleurisy and stress-induced gastric lesions in rats. Prost. Leuko. Essent. Fatty Acids, 55, 395402.
  • PENNING, T.D., TALLEY, J.J., BERTENSHAW, S.R., CARTER, J.S., COLLINS, P.W., DOCTER, S., GRANETO, M.J., LEE, L.F., MALECHA, J.W., MIYASHIRO, J.M., ROGERS, R.S., ROGIER, D.J., YU, S.S., ANDERSON, G.D., BURTON, E.G., COGBURN, J.N., GREGORY, S.A., KOBOLDT, C.M., PERKINS, W.E., SEIBERT, K., VEENHIZEN, A.W., ZHANG, Y.Y. & ISAKSON, P.C. (1997). Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase 2 inhibitors: identification of 4-[5-94-methylphenyl)-3-9 trifluoromethyl)-1H-pyrazol-1-yl]benzensulfonamide (SC 58635, celecoxib). J. Med. Chem., 140, 13471365.
  • REUTER, B.K., ASFAHA, S., BURET, A., SHARKEY, K.A. & WALLACE, J.L. (1996). Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2. J. Clin. Invest., 98, 20762085.
  • SCHMASSMANN, A., PESKAR, B.M., STETTLER, C., NETZER, P., STROFF, T., FLOGERZI, B. & HALTER, F. (1998). Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastro-intestinal ulcer models in rats. Br. J. Pharmacol., 123, 795804.
  • SEDGWICK, A.D., MOORE, A.R., AL-DUAIJ, A.Y., EDWARDS, J.C. & WILLOUGHBY, D.A. (1985). Studies into the influence of carrageenan-induced inflammation on articular cartilage degradation using implantation into air pouches. Br. J. Exp. Pathol., 66, 445453.
  • SEIBERT, K., ZHANG, Y., LEAHY, K., HAUSER, S., MASFERRER, J., PERKINS, W., LEE, L. & ISAKSON, P. (1994). Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc. Natl. Acad. Sci. U.S.A., 91, 1201312017.
  • VANE, J.R., MITCHELL, J.A., APPLETON, I., TOMLINSON, A., BISHOP-BAILEY, D., CROXTALL, J. & WILLOUGHBY, D.A. (1994). Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc. Natl. Acad. Sci. U.S.A., 91, 20462050.
  • WALLACE, J.L., BAK, A., MCKNIGHT, W., ASFAHA, S., SHARKEY, K.A. & MACNAUGHTON, W.K. (1998). Cyclooxygenase 1 contributes to inflammatory responses in rats and mice: Implications for gastrointestinal toxicity. Gastroenterology, 115, 101109.
  • XIE, W., CHIPMAN, J.G., ROBERTSON, D.L., ERIKSON, R.L. & SIMMONS, D.L. (1991). Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc. Natl. Acad. Sci. U.S.A., 88, 26922696.